Barrow, Hanley, Mewhinney & Strauss’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Barrow, Hanley, Mewhinney & Strauss's ACLS Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss opened a new position in Axcelis (ACLS) in Q1 2026: 57 shares worth $5.31K. The stake represents ﹤0.01% of the portfolio and ranks #268 among its holdings. This is a return to the name: Barrow, Hanley, Mewhinney & Strauss previously reported a position in ACLS as recently as Q2 2025.
Barrow, Hanley, Mewhinney & Strauss first reported a position in ACLS in Q2 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 57 shares of Axcelis worth $5.31K as of Q1 2026.
- Axcelis was a new Barrow, Hanley, Mewhinney & Strauss position in Q1 2026.
- Axcelis made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #268 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Axcelis in Q2 2025 and has held it in 2 quarters since.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.